Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Gastrointestinal Pathogen Testing Market Poised To Hit $5.06 Billion By 2030 With A 3.5% CAGR
The size of the gastrointestinal pathogen testing market has consistently increased over the past few years. It is projected to expand from $4.23 billion in 2025 to $4.41 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 4.2%. The expansion observed in previous periods can be linked to the high incidence of gastrointestinal infections, the utilization of culture-based testing, the growth of hospital laboratories, occurrences of foodborne illness outbreaks, and public health surveillance initiatives.
The gastrointestinal pathogen testing market size is anticipated to experience consistent expansion over the coming years. This market is projected to reach $5.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.5%. The expansion during this forecast period stems from several factors, including the increased adoption of syndromic testing panels, the broader availability of point-of-care diagnostics, the need for quicker turnaround times, the integration of molecular diagnostics, and heightened awareness regarding infectious diseases. Key developments expected in the forecast timeframe encompass the escalating utilization of multiplex molecular diagnostic panels, a greater demand for rapid stool testing, the wider deployment of point-of-care GI diagnostics, the increasing acceptance of PCR-based testing, and a stronger emphasis on infection surveillance.
Get A Free Sample Report With In-Depth Market Insights:
Gastrointestinal Pathogen Testing Market Demand Drivers: What’s Powering Industry Growth?
The increasing occurrence of foodborne illnesses is projected to boost the gastrointestinal pathogen testing market in the future. Foodborne diseases are conditions resulting from consuming contaminated food or drinks containing harmful microorganisms, toxins, or chemicals, encompassing conditions like listeriosis, viral gastroenteritis, taeniasis, and trichinosis. Several elements contribute to the increase in these incidents, such as shifts in food production, distribution, and consumption habits, insufficient food safety protocols, and the effects of climate change on food production. Gastrointestinal testing plays a crucial role in pinpointing the specific pathogens causing these illnesses, enabling healthcare providers to ascertain the root of symptoms, prescribe suitable treatments, monitor outbreaks, and implement preventative actions to curb the spread of foodborne diseases. For instance, in September 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, reported that during 2023, the CDC, with state and regulatory public health partners, investigated 181 possible multistate outbreaks, of which 84 were determined to be outbreaks. Of these, outbreak investigators solved 50 outbreaks (60%). A suspected source was identified for 22 outbreaks, and a confirmed source was identified for 28 outbreaks. Consequently, the growing frequency of foodborne diseases is a key factor propelling the expansion of the gastrointestinal pathogen testing market.
Gastrointestinal Pathogen Testing Market Segment Analysis: What Are The Core Market Categories?
The gastrointestinal pathogen testing market covered in this report is segmented –
1) By Pathogen Type: Bacteria, Viruses, Parasites
2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types
3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types
4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users
Subsegments:
1) By Bacteria: Salmonella spp., Escherichia coli, Campylobacter spp., Shigella spp., Clostridium difficile, Vibrio spp., Listeria monocytogenes, Helicobacter pylori, Other Bacterial Pathogens
2) By Viruses: Norovirus, Rotavirus, Enteric Adenovirus, Hepatitis A Virus (HAV), Astrovirus, Other Viral Pathogens
3) By Parasites: Giardia lamblia, Entamoeba histolytica, Cryptosporidium spp., Trichinella spp., Toxoplasma gondii, Other Parasitic Pathogens
Gastrointestinal Pathogen Testing Market Innovation Trends Shaping Future Development
Major companies operating in the gastrointestinal pathogen testing market are concentrating on developing sophisticated solutions, such as metagenomic diagnostic tests, to improve the accuracy, speed, and thoroughness of detecting gastrointestinal pathogens. A metagenomic diagnostic test is an advanced technology utilized to analyze the genetic material of microorganisms found in samples, including stool or blood. For instance, in April 2024, Microba Life Sciences, an Australia-based biotechnology company, introduced MetaPanel, a metagenomic diagnostic test designed to identify a wide array of gastrointestinal pathogens with unparalleled accuracy. MetaPanel covers 175 pathogen targets in a single test, providing healthcare professionals with an exhaustive solution for diagnosing both prevalent and hard-to-detect infections. It employs next-generation sequencing (NGS) technology to analyze an extensive range of genetic material within a stool sample. This allows for the identification of a diverse variety of potential pathogens, including those not regularly screened for in traditional GI (gastrointestinal) panels.
Gastrointestinal Pathogen Testing Market Top Companies Driving Competitive Growth
Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics
View The Full Gastrointestinal Pathogen Testing Market Report:
Gastrointestinal Pathogen Testing Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the gastrointestinal pathogen testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
